Anidulafungin in Treating Immunocompromised Children With Neutropenia

NCT00068471 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Infection
Neutropenia
Unspecified Childhood Solid Tumor, Protocol Specific

Interventions

DRUG: anidulafungin

Sponsor

National Cancer Institute (NCI)